Foamix Pharmaceuticals CEO On The Company's IPO, Status Of Trial Drugs

By: via Benzinga
Foamix Pharmaceuticals Ltd (NASDAQ: FOMX), a pharmaceutical company specializing in skin conditions, recently had a successful IPO in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.